Record Information |
---|
Version | 5.0 |
---|
Status | Detected but not Quantified |
---|
Creation Date | 2021-09-11 06:54:49 UTC |
---|
Update Date | 2021-09-26 23:01:06 UTC |
---|
HMDB ID | HMDB0249948 |
---|
Secondary Accession Numbers | None |
---|
Metabolite Identification |
---|
Common Name | 3beta-Hydroxy-17-(1H-imidazol-1-yl)androsta-5,16-diene |
---|
Description | 3beta-Hydroxy-17-(1H-imidazol-1-yl)androsta-5,16-diene belongs to the class of organic compounds known as androgens and derivatives. These are 3-hydroxylated C19 steroid hormones. They are known to favor the development of masculine characteristics. They also show profound effects on scalp and body hair in humans. Based on a literature review very few articles have been published on 3beta-Hydroxy-17-(1H-imidazol-1-yl)androsta-5,16-diene. This compound has been identified in human blood as reported by (PMID: 31557052 ). 3beta-hydroxy-17-(1h-imidazol-1-yl)androsta-5,16-diene is not a naturally occurring metabolite and is only found in those individuals exposed to this compound or its derivatives. Technically 3beta-Hydroxy-17-(1H-imidazol-1-yl)androsta-5,16-diene is part of the human exposome. The exposome can be defined as the collection of all the exposures of an individual in a lifetime and how those exposures relate to health. An individual's exposure begins before birth and includes insults from environmental and occupational sources. |
---|
Structure | CC12CCC3C(CC=C4CC(O)CCC34C)C1CC=C2N1C=CN=C1 InChI=1S/C22H30N2O/c1-21-9-7-16(25)13-15(21)3-4-17-18-5-6-20(24-12-11-23-14-24)22(18,2)10-8-19(17)21/h3,6,11-12,14,16-19,25H,4-5,7-10,13H2,1-2H3 |
---|
Synonyms | Value | Source |
---|
3b-Hydroxy-17-(1H-imidazol-1-yl)androsta-5,16-diene | Generator | 3Β-hydroxy-17-(1H-imidazol-1-yl)androsta-5,16-diene | Generator |
|
---|
Chemical Formula | C22H30N2O |
---|
Average Molecular Weight | 338.495 |
---|
Monoisotopic Molecular Weight | 338.235813594 |
---|
IUPAC Name | 14-(1H-imidazol-1-yl)-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadeca-7,13-dien-5-ol |
---|
Traditional Name | 14-(imidazol-1-yl)-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadeca-7,13-dien-5-ol |
---|
CAS Registry Number | Not Available |
---|
SMILES | CC12CCC3C(CC=C4CC(O)CCC34C)C1CC=C2N1C=CN=C1 |
---|
InChI Identifier | InChI=1S/C22H30N2O/c1-21-9-7-16(25)13-15(21)3-4-17-18-5-6-20(24-12-11-23-14-24)22(18,2)10-8-19(17)21/h3,6,11-12,14,16-19,25H,4-5,7-10,13H2,1-2H3 |
---|
InChI Key | PRBTWKCJXZGRAL-UHFFFAOYSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as androgens and derivatives. These are 3-hydroxylated C19 steroid hormones. They are known to favor the development of masculine characteristics. They also show profound effects on scalp and body hair in humans. |
---|
Kingdom | Organic compounds |
---|
Super Class | Lipids and lipid-like molecules |
---|
Class | Steroids and steroid derivatives |
---|
Sub Class | Androstane steroids |
---|
Direct Parent | Androgens and derivatives |
---|
Alternative Parents | |
---|
Substituents | - Androgen-skeleton
- 3-hydroxy-delta-5-steroid
- 3-hydroxysteroid
- Hydroxysteroid
- Delta-5-steroid
- N-substituted imidazole
- Azole
- Cyclic alcohol
- Heteroaromatic compound
- Imidazole
- Secondary alcohol
- Azacycle
- Organoheterocyclic compound
- Organopnictogen compound
- Alcohol
- Hydrocarbon derivative
- Organic oxygen compound
- Organic nitrogen compound
- Organonitrogen compound
- Organooxygen compound
- Aromatic heteropolycyclic compound
|
---|
Molecular Framework | Aromatic heteropolycyclic compounds |
---|
External Descriptors | Not Available |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | Not Available |
---|
Role | Not Available |
---|
Physical Properties |
---|
State | Not Available |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | | Show more...
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredictor | Adduct Type | CCS Value (Å2) | Reference |
---|
DeepCCS | [M-2H]- | 215.426 | 30932474 | DeepCCS | [M+Na]+ | 190.818 | 30932474 |
Predicted Kovats Retention IndicesUnderivatized | Show more...
---|
Spectra |
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted GC-MS | Predicted GC-MS Spectrum - 3beta-Hydroxy-17-(1H-imidazol-1-yl)androsta-5,16-diene GC-MS (Non-derivatized) - 70eV, Positive | splash10-07r0-0369000000-39f10a8819d7865b7c59 | 2021-09-23 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - 3beta-Hydroxy-17-(1H-imidazol-1-yl)androsta-5,16-diene GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - 3beta-Hydroxy-17-(1H-imidazol-1-yl)androsta-5,16-diene GC-MS (TMS_1_1) - 70eV, Positive | Not Available | 2021-11-03 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - 3beta-Hydroxy-17-(1H-imidazol-1-yl)androsta-5,16-diene GC-MS (TBDMS_1_1) - 70eV, Positive | Not Available | 2021-11-03 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 3beta-Hydroxy-17-(1H-imidazol-1-yl)androsta-5,16-diene 10V, Positive-QTOF | splash10-0079-0009000000-4753a92f9710dde12016 | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 3beta-Hydroxy-17-(1H-imidazol-1-yl)androsta-5,16-diene 20V, Positive-QTOF | splash10-00dj-0495000000-55b72732587e5a321bc6 | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 3beta-Hydroxy-17-(1H-imidazol-1-yl)androsta-5,16-diene 40V, Positive-QTOF | splash10-0q2c-4960000000-f5f1f680ed82133dfef4 | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 3beta-Hydroxy-17-(1H-imidazol-1-yl)androsta-5,16-diene 10V, Negative-QTOF | splash10-000i-0009000000-d49354e44fce9dda503b | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 3beta-Hydroxy-17-(1H-imidazol-1-yl)androsta-5,16-diene 20V, Negative-QTOF | splash10-000i-0009000000-8ceca6d701917ad3070e | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 3beta-Hydroxy-17-(1H-imidazol-1-yl)androsta-5,16-diene 40V, Negative-QTOF | splash10-00kr-3279000000-30ef04b6d9f530c7b2ee | 2021-10-12 | Wishart Lab | View Spectrum |
| Show more...
---|
Biological Properties |
---|
Cellular Locations | Not Available |
---|
Biospecimen Locations | |
---|
Tissue Locations | Not Available |
---|
Pathways | |
---|
Normal Concentrations |
---|
| |
Blood | Detected but not Quantified | Not Quantified | Not Specified | Not Specified | Normal | | details |
|
---|
Abnormal Concentrations |
---|
| Not Available |
---|
Associated Disorders and Diseases |
---|
Disease References | None |
---|
Associated OMIM IDs | None |
---|
External Links |
---|
DrugBank ID | Not Available |
---|
Phenol Explorer Compound ID | Not Available |
---|
FooDB ID | Not Available |
---|
KNApSAcK ID | Not Available |
---|
Chemspider ID | 13418982 |
---|
KEGG Compound ID | Not Available |
---|
BioCyc ID | Not Available |
---|
BiGG ID | Not Available |
---|
Wikipedia Link | Not Available |
---|
METLIN ID | Not Available |
---|
PubChem Compound | 18431051 |
---|
PDB ID | Not Available |
---|
ChEBI ID | Not Available |
---|
Food Biomarker Ontology | Not Available |
---|
VMH ID | Not Available |
---|
MarkerDB ID | Not Available |
---|
Good Scents ID | Not Available |
---|
References |
---|
Synthesis Reference | Not Available |
---|
Material Safety Data Sheet (MSDS) | Not Available |
---|
General References | - Barupal DK, Fiehn O: Generating the Blood Exposome Database Using a Comprehensive Text Mining and Database Fusion Approach. Environ Health Perspect. 2019 Sep;127(9):97008. doi: 10.1289/EHP4713. Epub 2019 Sep 26. [PubMed:31557052 ]
|
---|